Orthofix Medical (OFIX) EV to EBITDA (2010 - 2026)

Orthofix Medical (OFIX) has reported EV to EBITDA for 17 consecutive years, with 10.02 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA fell 22.02% year-over-year to 10.02; the trailing twelve-month figure through Jun 2026 stood at 2.33 (down 28.38% YoY), and the FY2025 full-year result was 4.36, down 16.6% from the prior year.
• EV to EBITDA was 10.02 for Q2 2026 at Orthofix Medical, down from 19.3 in the prior quarter.
• The five-year high for EV to EBITDA was 175.03 in Q1 2023, with the low at 10.02 in Q2 2026.
• Historically, EV to EBITDA has averaged 31.67 across 5 years, with a median of 18.9 in 2024.
• Annual changes were most pronounced in 2023 — EV to EBITDA soared 115.68% — and 2024, when it sank 84.05%.
• Tracing OFIX's EV to EBITDA over 5 years: stood at 10.33 in 2022, then jumped by 38.71% to 14.32 in 2023, then climbed by 14.72% to 16.43 in 2024, then fell by 16.72% to 13.68 in 2025, then declined by 26.78% to 10.02 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 10.02 in Q2 2026, 19.3 in Q1 2026, and 13.68 in Q4 2025.